Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE)
Clinical trial NCT07435584 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07435584
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2026-12-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.